Jan 22, 2018 12:00 pm UTC| Business
Seeking Distribution Partners in Europe for CE-Marked Electroceutical™ Device for Promotion of Wound Healing, Reduction of Pain and Post-Operative Edema LOS ANGELES, CA, Jan. 22, 2018 -- Endonovo Therapeutics,...
Jan 22, 2018 12:00 pm UTC| Business
VANCOUVER, British Columbia, Jan. 22, 2018 -- Isodiol International Inc., (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global bioactive phytoceutical innovator specializing in the development of...
Jan 22, 2018 12:00 pm UTC| Business
BUFFALO, N.Y., Jan. 22, 2018 -- Athenex (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related...
Jan 22, 2018 12:00 pm UTC| Business
BUFFALO, N.Y., Jan. 22, 2018 -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related...
Winners Announced for the National “Choices in Education” Video Contest
Jan 22, 2018 12:00 pm UTC| Business
Tallahassee, Jan. 22, 2018 -- Millions of American families – from single parent to rural families and parents of children with special needs – benefit from the opportunity to find the best educational fit for...
Kandou Bus Applauds the OIF on Publication of CEI 4.0
Jan 22, 2018 12:00 pm UTC| Business
LAUSANNE, Switzerland, Jan. 22, 2018 -- The Optical Internetworking Forum (OIF) has published their CEI 4.0 Interoperability Agreement (IA) that contains a clause using Ensemble Non-Return-to-Zero (ENRZ) signaling,...
uniQure Receives Orphan Medicinal Product Designation in Europe for AMT-130 in Huntington’s disease
Jan 22, 2018 12:00 pm UTC| Business
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Jan. 22, 2018 -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced...